Minimal change disease cost-effectiveness of therapy
Overview
Overview
Azathioprine may be cost effective in treating the patients with minimal change disease .
Cost-effectiveness of Therapy
Cost-effectiveness of Therapy
- Azathioprine therapy may used in glucocorticoid-resistant disease with the patients of minimal change disease.[1]
- Azathioprine is cost effective and may be as effective and less costly than MMF for this indication.
References
References
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
